Detalles de la búsqueda
1.
Real-world biologic treatment and associated cost in patients with inflammatory bowel disease.
Z Gastroenterol
; 57(7): 843-851, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31288280
2.
Primary data, claims data, and linked data in observational research: the case of COPD in Germany.
Respir Res
; 19(1): 161, 2018 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30165860
3.
Persistence with VKA treatment in newly treated atrial fibrillation patients: an analysis based on a large sample of 38,076 German patients.
Eur J Clin Pharmacol
; 73(11): 1437-1447, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28780697
4.
Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus.
Cardiovasc Diabetol
; 14: 14, 2015 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25645749
5.
Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-use.
J Thromb Thrombolysis
; 40(1): 97-107, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25218507
6.
Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients.
Europace
; 15(4): 486-93, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23220354
7.
Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany.
Clin Ther
; 42(1): 130-143.e3, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31883702
8.
Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset.
Pragmat Obs Res
; 9: 1-10, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29750067
9.
Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
Ger Med Sci
; 15: Doc09, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28638313
10.
Healthcare Burden and Costs Associated with Urinary Tract Infections in Type 2 Diabetes Mellitus Patients: An Analysis Based on a Large Sample of 456,586 German Patients.
Nephron
; 132(3): 215-26, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26930608
11.
Non-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis.
Diabetes Ther
; 7(1): 105-24, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26695499
12.
Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456,586 German T2DM patients.
J Diabetes Complications
; 29(8): 1015-23, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26476473
13.
Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study.
J Diabetes Metab Disord
; 15: 28, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-27486568
14.
Real life treatment of diabetes mellitus type 2 patients: an analysis based on a large sample of 394,828 German patients.
Diabetes Res Clin Pract
; 106(2): 275-85, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25176225
15.
How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus.
Eur J Health Econ
; 14(3): 551-68, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22815097
16.
Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
Thromb Haemost
; 107(6): 1053-65, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22398417
Resultados
1 -
16
de 16
1
Próxima >
>>